4//SEC Filing
Ballal Rahul D. 4
Accession 0001439222-25-000098
CIK 0001439222other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:55 PM ET
Size
6.9 KB
Accession
0001439222-25-000098
Insider Transaction Report
Form 4
Ballal Rahul D.
Director
Transactions
- Exercise/Conversion
Restricted stock units
2025-08-11−2,302→ 0 total→ Common stock (2,302 underlying) - Exercise/Conversion
Common stock
2025-08-11+2,302→ 12,414 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on August 11, 2022. Beginning on August 11, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001805097
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:55 PM ET
- Size
- 6.9 KB